9Oct2017 Where Does Alzheimer’s R&D Go Now? Plenty of Directions /Luke Timmerman/0/All, The Edge09 Oct 2017 Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.